Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Covid19-Sources
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
Severe Hepatitis in Pediatric COVID-19 - PubMed
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants | bioRxiv
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals
sigallab.net
North Carolina health officials watch for unusual hepatitis cases in children
SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases - PubMed
COVID-19 mortality preventable by vaccines - Peterson-KFF Health System Tracker
COVID-19 vaccine weekly surveillance reports (weeks 39 to 17, 2021 to 2022)
Philipp S. Holstein on Twitter
COVID-19 Associated Hepatitis in Children (CAH-C) during the second wave of SARS-CoV-2 infections in Central India: Is it a complication or transient phenomenon
Post-COVID‑19-Arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis
Cycle threshold values in symptomatic Covid-19 cases in England
Effects of COVID-19 in Care Homes - A Mixed Methods Review
Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the SARS-CoV-2 BA.1 and BA.2 Omicron variants
Der verkannte Impfstoff
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
Jan Hartmann on Twitter
Consumer-grade wearables identify changes in multiple physiological systems during COVID-19 disease progression
Durability of BNT162b2 vaccine against hospital and emergency
Aktuelle Bettenbelegung | Deutsche Krankenhausgesellschaft e. V.
The roles of nausea and vomiting in COVID-19: did we miss something?
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 | NEJM
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
Was gibt es Neues zu COVID-19?
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19
Chris Turnbull on Twitter